213 related articles for article (PubMed ID: 19856268)
1. New concepts and new weapons in implant infections.
Arciola CR
Int J Artif Organs; 2009 Sep; 32(9):533-6. PubMed ID: 19856268
[TBL] [Abstract][Full Text] [Related]
2. Susceptibility of staphylococcal biofilms to enzymatic treatments depends on their chemical composition.
Chaignon P; Sadovskaya I; Ragunah Ch; Ramasubbu N; Kaplan JB; Jabbouri S
Appl Microbiol Biotechnol; 2007 May; 75(1):125-32. PubMed ID: 17221196
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic potential of biofilm-dispersing enzymes.
Kaplan JB
Int J Artif Organs; 2009 Sep; 32(9):545-54. PubMed ID: 19851978
[TBL] [Abstract][Full Text] [Related]
4. Differential roles of poly-N-acetylglucosamine surface polysaccharide and extracellular DNA in Staphylococcus aureus and Staphylococcus epidermidis biofilms.
Izano EA; Amarante MA; Kher WB; Kaplan JB
Appl Environ Microbiol; 2008 Jan; 74(2):470-6. PubMed ID: 18039822
[TBL] [Abstract][Full Text] [Related]
5. Synergistic activity of dispersin B and cefamandole nafate in inhibition of staphylococcal biofilm growth on polyurethanes.
Donelli G; Francolini I; Romoli D; Guaglianone E; Piozzi A; Ragunath C; Kaplan JB
Antimicrob Agents Chemother; 2007 Aug; 51(8):2733-40. PubMed ID: 17548491
[TBL] [Abstract][Full Text] [Related]
6. In Vitro Antimicrobial Efficacy of Tobramycin Against Staphylococcus aureus Biofilms in Combination With or Without DNase I and/or Dispersin B: A Preliminary Investigation.
Waryah CB; Wells K; Ulluwishewa D; Chen-Tan N; Gogoi-Tiwari J; Ravensdale J; Costantino P; Gökçen A; Vilcinskas A; Wiesner J; Mukkur T
Microb Drug Resist; 2017 Apr; 23(3):384-390. PubMed ID: 27754780
[TBL] [Abstract][Full Text] [Related]
7. Maggot excretions inhibit biofilm formation on biomaterials.
Cazander G; van de Veerdonk MC; Vandenbroucke-Grauls CM; Schreurs MW; Jukema GN
Clin Orthop Relat Res; 2010 Oct; 468(10):2789-96. PubMed ID: 20309656
[TBL] [Abstract][Full Text] [Related]
8. Biofilm in implant infections: its production and regulation.
Costerton JW; Montanaro L; Arciola CR
Int J Artif Organs; 2005 Nov; 28(11):1062-8. PubMed ID: 16353112
[TBL] [Abstract][Full Text] [Related]
9. Biofilm extracellular-DNA in 55 Staphylococcus epidermidis clinical isolates from implant infections.
Ravaioli S; Campoccia D; Visai L; Pirini V; Cangini I; Corazzari T; Maso A; Poggio C; Pegreffi F; Montanaro L; Arciola CR
Int J Artif Organs; 2011 Sep; 34(9):840-6. PubMed ID: 22094564
[TBL] [Abstract][Full Text] [Related]
10. Poly-N-acetylglucosamine is not a major component of the extracellular matrix in biofilms formed by icaADBC-positive Staphylococcus lugdunensis isolates.
Frank KL; Patel R
Infect Immun; 2007 Oct; 75(10):4728-42. PubMed ID: 17635864
[TBL] [Abstract][Full Text] [Related]
11. Disruption of Staphylococcus epidermidis biofilms by medicinal maggot Lucilia sericata excretions/secretions.
Harris LG; Bexfield A; Nigam Y; Rohde H; Ratcliffe NA; Mack D
Int J Artif Organs; 2009 Sep; 32(9):555-64. PubMed ID: 19856274
[TBL] [Abstract][Full Text] [Related]
12. Virulence gene expression by Staphylococcus epidermidis biofilm cells exposed to antibiotics.
Gomes F; Teixeira P; Cerca N; Ceri H; Oliveira R
Microb Drug Resist; 2011 Jun; 17(2):191-6. PubMed ID: 21395450
[TBL] [Abstract][Full Text] [Related]
13. Does Extracellular DNA Production Vary in Staphylococcal Biofilms Isolated From Infected Implants versus Controls?
Zatorska B; Groger M; Moser D; Diab-Elschahawi M; Lusignani LS; Presterl E
Clin Orthop Relat Res; 2017 Aug; 475(8):2105-2113. PubMed ID: 28194715
[TBL] [Abstract][Full Text] [Related]
14. Combating implant infections. Remarks by a women's team.
Arciola CR; Balaban N; Baldassarri L; Fromm K; Hansch GM; Obst U; Presterl E; Stefani S; Verran J; Visai L
Int J Artif Organs; 2008 Sep; 31(9):858-64. PubMed ID: 18924099
[TBL] [Abstract][Full Text] [Related]
15. Surface coating strategies to prevent biofilm formation on implant surfaces.
Bruellhoff K; Fiedler J; Möller M; Groll J; Brenner RE
Int J Artif Organs; 2010 Sep; 33(9):646-53. PubMed ID: 20890881
[TBL] [Abstract][Full Text] [Related]
16. Unraveling the anti-biofilm potential of green algal sulfated polysaccharides against Salmonella enterica and Vibrio harveyi.
Vishwakarma J; V L S
Appl Microbiol Biotechnol; 2020 Jul; 104(14):6299-6314. PubMed ID: 32451587
[TBL] [Abstract][Full Text] [Related]
17. Extracellular polymeric substance (EPS)-degrading enzymes reduce staphylococcal surface attachment and biocide resistance on pig skin in vivo.
Kaplan JB; Mlynek KD; Hettiarachchi H; Alamneh YA; Biggemann L; Zurawski DV; Black CC; Bane CE; Kim RK; Granick MS
PLoS One; 2018; 13(10):e0205526. PubMed ID: 30304066
[TBL] [Abstract][Full Text] [Related]
18. Baicalin inhibits biofilm formation, attenuates the quorum sensing-controlled virulence and enhances Pseudomonas aeruginosa clearance in a mouse peritoneal implant infection model.
Luo J; Dong B; Wang K; Cai S; Liu T; Cheng X; Lei D; Chen Y; Li Y; Kong J; Chen Y
PLoS One; 2017; 12(4):e0176883. PubMed ID: 28453568
[TBL] [Abstract][Full Text] [Related]
19. Staphylococcus epidermidis biofilm on implant material is reduced by a covalently linked thiophenone.
Aamdal Scheie A; Chamgordani EJ; Naemi AO; Hansen FK; Benneche T
J Appl Microbiol; 2016 Aug; 121(2):547-53. PubMed ID: 27214405
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic and genotypic characterization of Staphylococci causing breast peri-implant infections in oncologic patients.
Barbieri R; Pesce M; Franchelli S; Baldelli I; De Maria A; Marchese A
BMC Microbiol; 2015 Feb; 15(1):26. PubMed ID: 25888077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
